China has five COVID-19 vaccines in phase III clinical trials

China has five vaccines for COVID-19 currently undergoing phase III clinical trials in some foreign countries, a Foreign Ministry spokesperson said Wednesday.

Spokesperson Zhao Lijian told a news briefing that since the outbreak of the COVID-19, the Chinese government adopted five technological approaches to developing COVID-19 vaccines, namely inactivated vaccines, recombinant protein vaccines, adenovirus vector vaccines, vaccines using attenuated influenza viruses as vectors, and nucleic acid vaccines.…

This news comes via, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.

Visit the original:

Comments are closed.